百诚医药:公司与Delim公司已正式签署战略合作协议

Group 1 - The core viewpoint of the article is that Baicheng Pharmaceutical has officially signed a strategic cooperation agreement with Delim Company, focusing on the development, production, and commercialization of innovative oral formulations for products such as Semaglutide, Tirzepatide, and Minoxidil [1] Group 2 - The collaboration aims to enhance the research and development capabilities of Baicheng Pharmaceutical in the field of innovative oral formulations [1] - The partnership is expected to accelerate the commercialization process of the mentioned products, potentially leading to increased market presence and revenue for the company [1]

Bio-S-百诚医药:公司与Delim公司已正式签署战略合作协议 - Reportify